|
[1]
|
崔书中. 恶性肿瘤的腹腔热灌注治疗技术[Z]. 广东省, 广州医科大学附属肿瘤医院, 2018-08-14.
|
|
[2]
|
Coelho, S.S., Silva, P.M. and Ramos, J. (1998) Carcinomatose Peritoneal. Acta Medica Portuguesa, 11, 585-589.
|
|
[3]
|
Bentrem, D., Wilton, A., Mazumdar, M., Brennan, M. and Coit, D. (2005) The Value of Peritoneal Cytology as a Preoperative Predictor in Patients with Gastric Carcinoma Undergoing a Curative Resection. Annals of Surgical Oncology, 12, 347-353. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yonemura, Y., Kawamura, T., Bandou, E., Tsukiyama, G., Endou, Y. and Miura, M. (2007) The Natural History of Free Cancer Cells in the Peritoneal Cavity. In: Advances in Peritoneal Surface Oncology, Springer, 11-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hayes, N., Wayman, J., Wadehra, V., Raimes, S.A. and Griffin, S.M. (1999) Peritoneal Cytology in the Surgical Evaluation of Gastric Carcinoma. British Journal of Cancer, 79, 520-524. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Verwaal, V.J., van Ruth, S., de Bree, E., van Slooten, G.W., van Tinteren, H., Boot, H., et al. (2003) Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy versus Systemic Chemotherapy and Palliative Surgery in Patients with Peritoneal Carcinomatosis of Colorectal Cancer. Journal of Clinical Oncology, 21, 3737-3743. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Acs, M., Babucke, M., Jusufi, M., Kaposztas, Z., Slowik, P., Hornung, M., et al. (2024) Current Clinical Practices of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Innovative Surgical Sciences, 9, 3-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fujimoto, S., Shrestha, R.D., Kokubun, M., Ohta, M., Takahashi, M., Kobayashi, K., et al. (1988) Intraperitoneal Hyperthermic Perfusion Combined with Surgery Effective for Gastric Cancer Patients with Peritoneal Seeding. Annals of Surgery, 208, 36-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Dedrick, R.L., Myers, C.E., Bungay, P.M. and DeVita, V.T. (1978) Pharmacokinetic Rationale for Peritoneal Drug Administration in the Treatment of Ovarian Cancer. Cancer Treatment Reports, 62, 1-11.
|
|
[10]
|
Bynum, G.D., Pandolf, K.B., Schuette, W.H., Goldman, R.F., Lees, D.E., Whang-Peng, J., et al. (1978) Induced Hyperthermia in Sedated Humans and the Concept of Critical Thermal Maximum. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 235, R228-R236. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Spratt, J.S., Adcock, R.A., Muskovin, M., Sherrill, W. and McKeown, J. (1980) Clinical Delivery System for Intraperitoneal Hyperthermic Chemotherapy. Cancer Research, 40, 256-260.
|
|
[12]
|
腹腔热灌注化疗技术临床应用专家协作组. 腹腔热灌注化疗技术临床应用专家共识(2016版) [J]. 中华胃肠外科杂志, 2016, 19(2): 121-125.
|
|
[13]
|
Vaughn, L.K., Bernheim, H.A. and Kluger, M.J. (1974) Fever in the Lizard Dipsosaurus dorsalis. Nature, 252, 473-474. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kluger, M.J. (1978) The Evolution and Adaptive Value of Fever. American Scientist, 66, 38-43.
|
|
[15]
|
Evans, S.S., Repasky, E.A. and Fisher, D.T. (2015) Fever and the Thermal Regulation of Immunity: The Immune System Feels the Heat. Nature Reviews Immunology, 15, 335-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Burd, R., Dziedzic, T.S., Xu, Y., Caligiuri, M.A., Subjeck, J.R. and Repasky, E.A. (1998) Tumor Cell Apoptosis, Lymphocyte Recruitment and Tumor Vascular Changes Are Induced by Low Temperature, Long Duration (Fever-Like) Whole Body Hyperthermia. Journal of Cellular Physiology, 177, 137-147. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Song, C.W., Park, H.J., Lee, C.K. and Griffin, R. (2005) Implications of Increased Tumor Blood Flow and Oxygenation Caused by Mild Temperature Hyperthermia in Tumor Treatment. International Journal of Hyperthermia, 21, 761-767. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
中国抗癌协会腹膜肿瘤专业委员会, 广东省抗癌协会肿瘤热疗专业委员会. 中国腹腔热灌注化疗技术临床应用专家共识(2019版) [J]. 清华大学学报, 中华医学杂志, 2020, 100(2): 89-96.
|
|
[19]
|
中国医师协会结直肠肿瘤专业委员会. 结直肠癌腹膜转移诊治专家共识(2025版) [J]. 中华胃肠外科杂志, 2025, 28(5): 441-449.
|
|
[20]
|
Bushati, M., Rovers, K.P., Sommariva, A., Sugarbaker, P.H., Morris, D.L., Yonemura, Y., et al. (2018) The Current Practice of Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases: Results of a Worldwide Web-Based Survey of the Peritoneal Surface Oncology Group International (PSOGI). European Journal of Surgical Oncology, 44, 1942-1948. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Kim, J., Kim, J.H., Oh, S. and Ahn, S.W. (2025) Comparison of Core Temperature Monitoring Methods during Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Prospective Observational Study. European Journal of Medical Research, 30, Article No. 908. [Google Scholar] [CrossRef]
|
|
[22]
|
Kang, H.X., Ma, J.Y., Su, Y.Y., Kang, S., Feng, B., Feng, X., et al. (2023) Risk Factors of Temperature Increase after Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy. Frontiers in Oncology, 13, Article ID: 1120499. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
刘旺, 李峰. 腹腔热灌注化疗在结直肠癌中的临床应用进展[J]. 湘南学院学报(医学版), 2020, 22(2): 71-75.
|
|
[24]
|
Cheng, Y., Weng, S., Yu, L., Zhu, N., Yang, M. and Yuan, Y. (2019) The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors. Integrative Cancer Therapies, 18. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Dai, Q., Cao, B., Zhao, S. and Zhang, A. (2022) Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future. Bioengineering, 9, Article No. 474. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Meyer, R.E., Braun, R.D., Rosner, G.L. and Dewhirst, M.W. (2000) Local 42 ˚C Hyperthermia Improves Vascular Conductance of the R3230ac Rat Mammary Adenocarcinoma during Sodium Nitroprusside Infusion. Radiation Research, 154, 196-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Shen, Y., Liu, P., Zhang, A. and Xu, L.X. (2008) Study on Tumor Microvasculature Damage Induced by Alternate Cooling and Heating. Annals of Biomedical Engineering, 36, 1409-1419. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Dunne, M., Regenold, M. and Allen, C. (2020) Hyperthermia Can Alter Tumor Physiology and Improve Chemo-and Radio-Therapy Efficacy. Advanced Drug Delivery Reviews, 163, 98-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Dhaliwal, A. and Zheng, G. (2019) Improving Accessibility of EPR-Insensitive Tumor Phenotypes Using EPR-Adaptive Strategies: Designing a New Perspective in Nanomedicine Delivery. Theranostics, 9, 8091-8108. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Ojha, T., Pathak, V., Shi, Y., Hennink, W.E., Moonen, C.T.W., Storm, G., et al. (2017) Pharmacological and Physical Vessel Modulation Strategies to Improve EPR-Mediated Drug Targeting to Tumors. Advanced Drug Delivery Reviews, 119, 44-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Gabano, E., Colangelo, D., Ghezzi, A.R. and Osella, D. (2008) The Influence of Temperature on Antiproliferative Effects, Cellular Uptake and DNA Platination of the Clinically Employed Pt(II)-Drugs. Journal of Inorganic Biochemistry, 102, 629-635. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Landon, C.D., Benjamin, S.E., Ashcraft, K.A. and Dewhirst, M.W. (2013) A Role for the Copper Transporter Ctr1 in the Synergistic Interaction between Hyperthermia and Cisplatin Treatment. International Journal of Hyperthermia, 29, 528-538. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Wallner, K.E., DeGregorio, M.W. and Li, G.C. (1986) Hyperthermic Potentiation of Cis-Diamminedichloroplatinum(II) Cytotoxicity in Chinese Hamster Ovary Cells Resistant to the Drug. Cancer Research, 46, 6242-6245.
|
|
[34]
|
Arora, J.S., Murad, H.Y., Ashe, S., Halliburton, G., Yu, H., He, J., et al. (2016) Ablative Focused Ultrasound Synergistically Enhances Thermally Triggered Chemotherapy for Prostate Cancer in Vitro. Molecular Pharmaceutics, 13, 3080-3090. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Bull, J.M.C. (2018) A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response? International Journal of Hyperthermia, 34, 840-852. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Lim, P.Q., Han, I.H., Seow, K.M. and Chen, K.H. (2022) Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers. International Journal of Molecular Sciences, 23, Article No. 10078. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Bartos, A., Bartos, D., Herdean, A., Szabo, B., Militaru, C., Raluca, S., Calin, M., Iancu, C. and Breazu, C. (2018) Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Mechanisms of Action and the Role of HIPEC in the Treatment of Peritoneal Carcinomatosis. Annals of Italian Surgery, 89, 513-527.
|
|
[38]
|
徐能, 陈振, 钟艳红. 肿瘤细胞减灭术联合腹腔热灌注化疗治疗结直肠癌异时性腹膜转移的效果及预后影响因素探讨[J]. 医师在线, 2024, 14(10): 3-7.
|
|
[39]
|
Siegel, R.L., Kratzer, T.B., Giaquinto, A.N., Sung, H. and Jemal, A. (2025) Cancer Statistics, 2025. CA: A Cancer Journal for Clinicians, 75, 10-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Martins, M., Santos-Sousa, H., Araújo, F., Nogueiro, J. and Sousa-Pinto, B. (2022) Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 29, 7528-7537. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Ruff, S.M. (2025) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Metastases. Surgical Oncology Clinics of North America, 34, 241-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Patel, A.K., Sethi, N.S. and Park, H. (2026) Gastric Cancer: A Review. JAMA, 335, 439-450. [Google Scholar] [CrossRef]
|
|
[44]
|
Guo, J., Deng, Z., Jin, L., Yin, S., Xiong, Z., Wang, C., et al. (2023) Prognostic Value of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Synchronous Peritoneal Metastases: A Real-World Retrospective Study. Journal of Cancer Research and Clinical Oncology, 149, 17881-17896. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Rau, B., Lang, H., Koenigsrainer, A., Gockel, I., Rau, H., Seeliger, H., et al. (2024) Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer with Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial. Journal of Clinical Oncology, 42, 146-156. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Stefano, M., Perrina, D., Vallicelli, C., Ansaloni, L., Fugazzola, P., Coccolini, F., et al. (2024) Prophylaxis and Treatment of Peritoneal Carcinomatosis of Gastric Origin Using Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Trials. Journal of Gastrointestinal Surgery, 28, 1185-1193. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
吉冯飞, 张继业, 任相儒, 等. 腹腔热灌注化疗联合全身静脉化疗在胃癌根治术后的应用效果[J]. 临床医学, 2024, 44(9): 22-24.
|
|
[48]
|
张红巧, 刘鸥飞, 索丹风, 等. 腹腔热灌注联合XELOX化疗方案治疗胃癌腹腔积液的效果[J]. 河南医学研究, 2024, 33(15): 2735-2738.
|
|
[49]
|
李松, 黄汝金, 田圣威. 顺铂与白介素-2腹腔热灌注化疗对晚期胃癌患者疗效、肿瘤侵袭转移相关指标及生存期的影响[J]. 海南医学, 2025, 36(23): 3406-3412.
|
|
[50]
|
李曼, 石庆芳, 高军, 等. 信迪利单抗联合腹腔热灌注化疗一线治疗晚期胃癌的疗效与安全性分析[J]. 临床肿瘤学杂志, 2025, 30(10): 1006-1010.
|
|
[51]
|
Zeng, L., Liao, Q., Zeng, X., Ye, J., Yang, X., Zhu, S., et al. (2022) Noncoding RNAs and Hyperthermic Intraperitoneal Chemotherapy in Advanced Gastric Cancer. Bioengineered, 13, 2623-2638. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
李檞, 孙龙和, 邹嘉诚, 等. 细胞减灭术联合腹腔热灌注化疗治疗T3~4期结直肠癌患者的临床疗效[J]. 实用临床医药杂志, 2025, 29(23): 129-135.
|
|
[53]
|
李福, 任宝清, 郭晨媛, 等. 预防性腹腔热灌注化疗治疗结直肠癌的临床研究[J]. 中国肿瘤临床, 2024, 51(24): 1267-1272.
|
|
[54]
|
邢雅军. 腹腔灌注化疗联合全身静脉化疗治疗结直肠癌合并恶性腹腔积液的效果及安全性分析[J]. 大医生, 2024, 9(17): 24-26.
|
|
[55]
|
刘金彦, 刘娜, 任宛丽. 高危预警模式干预及健康教育在HIPEC治疗胰腺癌患者中的应用[J]. 广东医学, 2020, 41(5): 531-536.
|
|
[56]
|
周家瑜, 夏涛, 牟一平, 等. 腹腔镜胰体尾癌根治术中联合腹腔热灌注化疗的短期疗效分析[C]//浙江省医学会肿瘤外科学分会, 浙江省自然科学基金委员会. 2016浙江省肿瘤外科学术年会暨第二届钱江国际肿瘤外科高峰论坛论文汇编. 2016: 119-120.
|
|
[57]
|
夏利桦. 姑息性手术联合腹腔热灌注化疗治疗进展期胆管癌的疗效评价[D]: [硕士学位论文]. 广州: 广州医科大学, 2018.
|
|
[58]
|
李壮, 刘勇, 朱峰. 肝切除术联合腹腔热灌注化疗对肝癌患者术后复发性肝癌的预后分析[J]. 肝脏, 2025, 30(7): 930-933.
|
|
[59]
|
Caruso, G., Weroha, S.J. and Cliby, W. (2025) Ovarian Cancer: A Review. JAMA, 334, 1278-1291. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
姚秀玲, 王立霞, 梁焕, 等. 精准持续循环腹腔热灌注化疗联合静脉化疗在卵巢癌术后患者中的应用效果[J]. 分子诊断与治疗杂志, 2025, 17(4): 759-762+766.
|
|
[61]
|
Zhang, M., Bao, Y., Zhang, H., Li, D., Mei, X. and Cheng, X. (2023) Efficacy and Safety of Intraperitoneal Bevacizumab Combined with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Patients with Ovarian Cancer and Peritoneal Effusion and the Effect on Serum lncRNA H19 and VEGF Levels. Journal of Obstetrics and Gynaecology, 43, Article ID: 2204940. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
许倩, 朱竞婧, 王黎. 贝伐珠单抗用于卵巢癌并腹腔积液患者腹腔热灌注化疗效果评价[J]. 中国药业, 2025, 34(6): 95-98.
|
|
[63]
|
魏凯丽, 唐露, 方灿途, 等. 重组改构人肿瘤坏死因子联合腹腔热灌注化疗治疗卵巢癌胸腹水1例[J]. 临床肿瘤学杂志, 2025, 30(6): 623-624.
|
|
[64]
|
高艳艳, 何玉萍. 腹腔热灌注化疗用于复发性卵巢癌的临床效果[J]. 临床医学研究与实践, 2024, 9(32): 91-94.
|
|
[65]
|
Weaver, C.H. (1937) Mucocele of Appendix with Pseudomucinous Degeneration. The American Journal of Surgery, 36, 523-526. [Google Scholar] [CrossRef]
|
|
[66]
|
Yannamani, P., Chungu, L., Shetty, R. and Oyewole, B. (2024) Pseudomyxoma Peritonei Peritonitis. BMJ Case Reports, 17, e260759. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
吴启越, 雷子颖, 黄立峰, 等. 腹膜假黏液瘤临床诊治研究进展[J]. 消化肿瘤杂志(电子版), 2025, 17(2): 195-203.
|
|
[68]
|
Mittal, R., Chandramohan, A. and Moran, B. (2017) Pseudomyxoma Peritonei: Natural History and Treatment. International Journal of Hyperthermia, 33, 511-519. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Bartoška, P., Antoš, F., Vítek, P., Marx, J., Kopic, J. and Holečková, P. (2019) Pseudomyxoma Peritonei. Klinicka Onkologie, 32, 329-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Nawaz, A., Karakurum, A., Weltman, D., Shehata, A., Mohammed, I., Hadjiyane, C., et al. (2000) Pseudomyxoma Peritonei Manifesting as Intestinal Obstruction. Southern Medical Journal, 93, 891-893. [Google Scholar] [CrossRef]
|
|
[71]
|
Harshen, R., Jyothirmayi, R. and Mithal, N. (2003) Pseudomyxoma Peritonei. Clinical Oncology, 15, 73-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
O’Connell, J.T., Hacker, C.M. and Barsky, S.H. (2002) MUC2 Is a Molecular Marker for Pseudomyxoma Peritonei. Modern Pathology, 15, 958-972. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Choudry, H.A., O’Malley, M.E., Guo, Z.S., Zeh, H.J. and Bartlett, D.L. (2012) Mucin as a Therapeutic Target in Pseudomyxoma Peritonei. Journal of Surgical Oncology, 106, 911-917. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Zhao, Q., Wei, T., Ma, R., Fu, Y., Yang, R., Su, Y., et al. (2024) Progress on Immuno-Microenvironment and Immune-Related Therapies in Patients with Pseudomyxoma Peritonei. Cancer Biology & Medicine, 21, 586-605. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Yang, R., Zhao, X., Fu, Y., Lin, Y., Ma, R., Su, Y., et al. (2023) Etiological Analysis of Infection after CRS + HIPEC in Patients with Pmp. BMC Cancer, 23, Article No. 903. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Chun, C., Song, L., Zhang, H., Guo, D., Xu, G., Li, Y., et al. (2023) Malignant Peritoneal Mesothelioma. The American Journal of the Medical Sciences, 365, 99-103. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Miller, J. and Wynn, W.H. (1908) A Malignant Tumour Arising from the Endothelium of the Peritoneum, and Producing a Mucoid Ascitic Fluid. The Journal of Pathology and Bacteriology, 12, 267-278. [Google Scholar] [CrossRef]
|
|
[78]
|
Marinaccio, A., Binazzi, A., Marzio, D.D., Scarselli, A., Verardo, M., Mirabelli, D., et al. (2011) Pleural Malignant Mesothelioma Epidemic: Incidence, Modalities of Asbestos Exposure and Occupations Involved from the Italian National Register. International Journal of Cancer, 130, 2146-2154. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Helm, J.H., Miura, J.T., Glenn, J.A., Marcus, R.K., Larrieux, G., Jayakrishnan, T.T., et al. (2014) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis. Annals of Surgical Oncology, 22, 1686-1693. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
杨智冉, 苏延冬, 杨锐, 等. 肿瘤细胞减灭术联合腹腔热灌注治疗恶性腹膜间皮瘤的并发症及危险因素分析[J]. 中国肿瘤临床, 2023, 50(13): 661-666
|
|
[81]
|
中国抗癌协会肿瘤麻醉与镇痛专业委员会, 中华医学会麻醉学分会肿瘤与麻醉学组. 肿瘤细胞减灭术联合腹腔热灌注化疗麻醉暨围术期管理专家共识(2022版) [J]. 中华麻醉学杂志, 2022, 42(7): 794-806.
|